4//SEC Filing
Thompson Alexis A. 4
Accession 0000899243-22-011617
CIK 0001629137other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:58 PM ET
Size
7.5 KB
Accession
0000899243-22-011617
Insider Transaction Report
Form 4
Thompson Alexis A.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-17+2,400→ 2,400 total - Exercise/Conversion
Restricted Stock Units
2022-03-17−2,400→ 4,800 total→ Common Stock (2,400 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]The shares of Common Stock underlying the RSUs vest in three equal annual installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001851895
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:58 PM ET
- Size
- 7.5 KB